Document is current
Any future updates will be listed below
-
Authors
Silpa-archa, Sukhum https://orcid.org/0000-0002-3903-1889
Nganthavee, Variya
Chotcomwongse, Peranut
Lalitwongsa, Pawas
Ruamviboonsuk, Paisan
- License Information
-
More Information
Article History
Received: 20 March 2025
Accepted: 12 May 2025
First Online: 7 June 2025
Declarations
:
: Paisan Ruamviboonsuk has received grants from Roche; is a consultant for Roche; and has received speaker fees from Novartis, Roche, Bayer, and Topcon. Paisan Ruamviboonsuk is an Editorial Board member of Ophthalmology and Therapy. Paisan Ruamviboonsuk was not involved in the selection of peer reviewers for the manuscript nor any of the subsequent editorial decisions. Sukhum Silpa-archa, Variya Nganthavee, Peranut Chotcomwongse, and Pawas Lalitwongsa declare that they have no competing interests.
: This study followed the principles outlined in the Declaration of Helsinki and was approved by the Ethics Committee of Rajavithi Hospital (approval no. 053/2564). All patients giving informed consent for participation were enrolled from January 2016 to June 2023.
